Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain
Individuals on GLP-1s might not regain this muscle mass when or iif they discontinue the drugs
Pendulum put the 'pro' in probiotics Doctor-formulated Founded by PhD doctors and scientists from Johns Hopkins, Harvard, Berkeley, and Stanford Clinical efficacy Created Glucose Control, the only medical probiotic on the market clinically shown to improve A1C in type 2 diabetes Proprietary strains Featuring strains you can't get anywhere else, including live Akkermansia, a keystone strain that's been in 3,000+ scientific publications Cutting-edge research We continue to drive microbiome research forward through our own rigorous research and partnerships in clinical trials Revolutionary manufacturing Next-generation anaerobic strains are manufactured in our own strict, oxygen-free facility in the U.S.
With regular use, your skin becomes visibly more even, radiant and resilient
Study findings The study cohort consisted of 36,082 and 234,028 GLP-1 receptor agonist and DPP-4 inhibitor users, respectively, who were followed for a median of 1.3 and 1.7 years
Choose a plan that suits your needs and enjoy monthly benefits at exclusive prices